<- Go Home
Bonesupport Holding AB (publ)
Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also provides CERAMENT Bead Tray, an adjunctive local delivery option for surgeons desiring targeted delivery to osseous defects and for dead space management. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.
Market Cap
SEK 15.6B
Volume
238.6K
Cash and Equivalents
SEK 455.3M
EBITDA
SEK 322.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
SEK 1.1B
Profit Margin
92.48%
52 Week High
SEK 346.40
52 Week Low
SEK 165.00
Dividend
N/A
Price / Book Value
16.58
Price / Earnings
85.33
Price / Tangible Book Value
16.85
Enterprise Value
SEK 15.1B
Enterprise Value / EBITDA
45.81
Operating Income
SEK 320.1M
Return on Equity
22.04%
Return on Assets
19.86
Cash and Short Term Investments
SEK 455.3M
Debt
SEK 14.1M
Equity
SEK 938.9M
Revenue
SEK 1.2B
Unlevered FCF
SEK 204.7M
Sector
Biotechnology
Category
N/A